Home > Drug Search >
  • company_query: Axelar
  •   > 
Drug Filter
Category:
chemistry (35) biology (5)
Status:
Approved (1) Phase Ⅲ (4) Phase Ⅱ (19) Phase Ⅰ (16)
Clinical Stage:
Pending (14) Active (20) Discontinued (5)
Bio-Type:
Vaccine (3) Recombinant enzyme (1) Recombinant cytokines (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Asthma (1) Bone marrow cancer (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (3) Chronic myeloid leukemia (CML ) (1) Chronic obstructive pulmonary disease (COPD) (1) Giardia lamblia disease (1) Vaginal trichomoniasis (1) Cystic fibrosis (CF) (2) Amoebiasis (1) Trichomoniasis (1) Dry eye disease (1) Dyslipidemia (1) Follicular lymphoma (1) Fragile X syndrome (1) Glioblastoma multiforme (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) HSV infection (1) Huntington's disease (1) Hypercholesterolemia (1) Lymphoma (3) Medulloblastoma (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (1) Prader-Willi syndrome (1) Prostate cancer (1) Renal cell carcinoma (1) Solid tumours (8) Type 2 diabetes (4) Head and neck cancer (1) Colorectal cancer (1) Neuroblastoma (1) Malignant glioma (1) Spinal cord injury (1) Acute radiation syndrome (1) Chemotherapy-radiotherapy induced mucositis (1) Rett's syndrome (1) Brain injury (1) Astrocytoma (1) Neurotrophic Keratitis (NK) (1) venous stasis ulcers (1) Bacterial Vaginosis (BV) (1) Chronic myelomonocytic leukemia(CMML) (1) hematological malignancies (2) Chronic fatigue syndrome (1) Dental pain (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top